Technical Specifications
| Drug Composition | Ifosfamide 1 gm with Mesna 100 mg |
|---|---|
| Variant / Strength | 1 gm + 100 mg |
| Dosage Form / Type | Injectables |
| Product Benefits | Treatment different kinds of Cancer |
| Packaging Type | Vial |
| Delivery Time | 7 - 15 Days, as per delivery location. |
| Country of Origin | Made in India |
| Export Destinations | USA, UK, UAE, Philippines, Thailand, Kenya, Nigeria, Germany, Canada, Mexico, and 65+ more countries |
| Export Route | Shipped via temperature-controlled international air courier with full customs documentation |
Product Overview & Description
Ifoxan + Mesna Injection is a prescribed medication combining two agents crucial in cancer treatment. Its function involves impeding the growth and multiplication of cancer cells, leading to the destruction of tumors.
Administered exclusively under the supervision of a healthcare professional, self-administration of Ifoxan + Mesna Injection is strongly discouraged. It is imperative to communicate any known allergies to the medication to your doctor.
Common side effects of this medication encompass nausea, vomiting, hair loss, anemia, and a reduction in white blood cell count. Your doctor may recommend blood tests before or during the course of treatment to monitor potential effects on blood cell counts.
Submit Quotation Request
Verified Customer Reviews (0)
Frequently Asked Questions
ℹ️ Information reviewed by Medibliss Lifesciences Editorial Team. Last reviewed: August 2026. Data sourced from manufacturer documentation and WHO-GMP certificates.
Disclaimer: The information provided on this page is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Medibliss Lifesciences acts solely as an exporter and supplier. Please consult your physician or a qualified healthcare provider before starting any medication. We do not manufacture these products and rely on the manufacturer's provided documentation and WHO-GMP certifications for product information.